Review: Chronic Ischemic Mitral Regurgitation
Erwan Donal MD, Franck Levy MD, Christophe Tribouilloy MD

Aortic Valve Sclerosis is Associated with an Echocardiographically Determined Thinner Aortic Wall
Simon W. Rabkin MD, John Jue MD, Michael Y. Tsang BSc

Prevalence of Atherosclerosis of the Coronary and Extracranial Cerebral Arteries in Patients Undergoing Aortic Valve Replacement for Calcified Stenosis
Hiroshi Izumoto MD, Kohei Kawazoe MD, Takanori Oka MD, Toshinobu Kazui MD, Tetsunori Kawase MD, Masataka Nasu MD

Aortic Valve Repair for Aortic Regurgitation: Intermediate-term Results in Patients with Tricuspid Morphology
Alessandro Della Corte MD, Luca S. De Santo MD, Stefania Montagnani MD, Cesare Quarto MD, Gianpaolo Romano MD, Cristiano Amarelli MD, Michelangelo Scardone MD, Marisa De Feo MD, Maurizio Cotrufo MD, Giuseppe Caianiello MD

Hemolysis, High-Intensity Transient Signals (HITS) and Hemodynamic Results after Aortic Valve Replacement with the Medtronic Hall Easy-Fit™ Heart Valve Prosthesis
Roland H. Warnecke MD, Joachim Laas MD, Hartmut Hecker MD, Matthias Perthel MD, Aiman Alken MD

The Valve of Choice in Elderly Patients and its Influence on Quality of Life: A Long-Term Comparative Study
Paul A. Kurlansky MD, Donald B. Williams MD, Ernest A. Traad MD, Roger G. Carrillo MD, John S. Schor MD, Melinda Zucker BSN, George Ebra EdD

Valve Surgery in Octogenarians: A Safe Option with Good Medium-Term Results
Andrew Chukwuemeka MD, Michael A. Borger MD, Joan Ivanov PhD, Susan Armstrong MSc, Christopher Feindel MD, Tirone David MD

Long-Term Outcome of the Mitroflow Pericardial Bioprosthesis in the Elderly after Aortic Valve Replacement
Johan Sjögren MD,Tomas Gudbjartsson MD, Lars I. Thulin MD

Editorial: Cardiac Resynchronization Therapy as an Alternative to Valve Replacement in High-Risk Patients with a Chronically Decompensated Aortic Stenosis?
Dieter Horstkotte MD, Cornelia Piper MD, Jürgen Vogt MD, Barbara Lamp MD, Anja Dorszewski MD

Cardiac Resynchronization Therapy as an ‘Alternative’ Approach to a Non-Operable Severe Aortic Stenosis with Left Ventricular Dysfunction
Francesco Antonini-Canterin MD, Ferdinando Baldessin MD, Marco Brieda MD, Ermanno Dametto MD, Enzo Hrovatin MD, Fabio Zardo MD, Gian Luigi Nicolosi MD

Transmural Left Ventricular Shear Strain Alterations Adjacent to and Remote from Infarcted Myocardium
Allen Cheng, Frank Langer, Tom C. Nguyen, Marcin Malinowski, Daniel B. Ennis, George T. Daughters, Neil B. Ingels, Jr., D. Craig Miller

A Preoperative and Intraoperative Predictive Model of Prolonged Intensive Care Unit Stay for Valvular Surgery
Jianping Xu MD, Yipeng Ge ChM, Shiwei Pan MD, Feng Liu MD, Yi Shi ChM

Clinical Anatomy of the Atrioventricular Node Artery
Denis Berdajs MD, Andreas Künzli MD, Ulrich Shurr MD, Gregor Zünd MD, Marko I. Turina MD, Michele Genonni MD

Quattro Valve Trial at Mid-Term: December 1996 to November 2004
Robert W. M. Frater MD, Martin Sussman MD, Shirley Middlemost MD, Thomas Walther MD, Frederick Mohr MD, Zohair Al Halees MD, Maie Shahid MD

Stented Bioprosthetic Valve Hemodynamics: Is the Supra-Annular Implant Better than the Intra-Annular?
Luigi P. Badano, Daisy Pavoni, Sergio Musumeci, Romeo Frassani, Pasquale Gianfagna, Mara Baldassi, Vincenzo Tursi, Enzo Mazzaro, Edlira Zakja, Paolo M. Fioretti, Ugolino Livi

Eight-Year Results of Freestyle Stentless Bioprosthesis in the Aortic Position: A Single-Center Study of 500 Patients
Philippe H. Deleuze MD, Yves Fromes MD, Wassim Khoury MD, Philippe Maribas MD, Sacha Lemaire MD, Olivier M. Bical MD

Fate of the Autograft and Homograft Following Ross Aortic Valve Replacement: Reoperative Frequency, Outcome, and Management
John W. Brown MD, Mark Ruzmetov MD, PhD, Toshihiro Fukui MD, Mark D. Rodefeld MD, Yousuf Mahomed MD, Mark W. Turrentine MD

Preoperative Cholesterol Levels do not Predict Explant for Structural Valve Deterioration in Patients Undergoing Bioprosthetic Aortic Valve Replacement
Christian N. Gring MD, Penny Houghtaling MS, Gian M. Novaro MD, Eric Roselli MD, Nicholas Smedira MD, Michael Banbury MD, Eugene Blackstone MD, Brian P. Griffin MD

Reduction of Calcification of Carbodiimide-Processed Heart Valve Tissue by Prior Blocking of Amine Groups with Monoaldehydes
Frank Everaerts MSc, Mirian Gillissen BSc, Mark Torrianni MSc, Peter Zilla MD, Paul Human PhD, Marc Hendriks PhD, Jan Feijen PhD

Decellularization does not Eliminate Thrombogenicity and Inflammatory Stimulation in Tissue-Engineered Porcine Heart Valves
Marie-Theres Kasimir MD, Erwin Rieder MD, Gernot Seebacher MD, Anneliese Nigisch, Barbara Dekan, Ernst Wolner MD, Guenter Weigel MD, Paul Simon MD

Flow-Dependent Re-Endothelialization of Tissue-Engineered Heart Valves
Artur Lichtenberg MD, Serghei Cebotari MD, Igor Tudorache, Gerrit Sturz, Michael Winterhalter MD, Andres Hilfiker PhD, Axel Haverich MD

Cyclic Aortic Pressure Affects the Biological Properties of Porcine Pulmonary Valve Leaflets
Josepha D. Ikhumetse, Suchitra Konduri MS, James N. Warnock PhD, Yun Xing PhD, Ajit P. Yoganathan PhD

In response to
Bodnar E, Blackstone EH. Editorial: An ‘actual’ problem: Another issue of apples and oranges.
J Heart Valve Dis 2005;14:706-708
William N. Anderson PhD

In response to
Bodnar E, Blackstone EH. Editorial: An ‘actual’ problem: Another issue of apples and oranges.
J Heart Valve Dis 2005;14:706-708
Gary L. Grunkemeier PhD, Johanna J. M. Takkenberg MD, W. R. Eric Jamieson MD, D. Craig Miller MD

Reply
Endre Bodnar MD, Eugene H. Blackstone MD